North America LDL Test Market Size & Outlook, 2025-2033


North America LDL Test Market Insights

  • Based on Reed Intelligence findings, the North America LDL Test Market size reached USD 2634.13 Million in 2024 and is expected to grow to USD 4652.15 Million by 2033.
  • During 2026–2033, the market is forecasted to advance at a CAGR of 6.43%.
  • LDL-C represented the largest share of the By Type market in terms of size in 2024.
  • Among the By Type segments, LDL-C is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.

Other Key Findings


  • The global LDL Test Market size saw North America holding a share of 30.07% in 2024.
  • United States is forecasted to account for the leading share of the global market by 2033.
  • In North America, United States is forecasted to be the fastest-expanding market, projected to reach USD 3698.62 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 2634.13 Million
Market Size In 2033 USD 4652.15 Million
Largest segment LDL-C
Units Revenue in USD Million
CAGR 6.43% (2025-2033)
Segmnetation Covered
North America
  1. United States
  2. Canada
By Type
  1. LDL-C
  2. LDL-P
  3. LDL-B
  4. Others
By Component
  1. Devices
  2. Kits and Reagents
  3. Others
By Applications
  1. Atherosclerosis
  2. Obesity
  3. Dyslipidemia
  4. Diabetes
  5. Angina
  6. Stroke Carotid Artery Disease
  7. Peripheral Arterial Disease
  8. Others
By End-User
  1. Hospitals
  2. Clinics
  3. Pharmaceutical and Biotechnological Companies
  4. Diagnostic Centers
  5. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends